The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agentsin vitro

Data Mining Validation of Fluconazole Breakpoints Established by the European Committee on Antimicrobial Susceptibility Testing

(2009) I. Cuesta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds

(2009) M. Cuenca-Estrella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Incidence of zygomycosis in transplant recipients

(2009) M. Cuenca-Estrella et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antifungal drug resistance: do molecular methods provide a way forward?

(2009) David S Perlin   CURRENT OPINION IN INFECTIOUS DISEASES

Trends in antifungal susceptibility testing using CLSI reference and commercial methods

(2009) Emilia Cantón et al.   Expert Review of Anti-Infective Therapy

Reliability of the WIDERYST Susceptibility Testing System for Detection of In Vitro Antifungal Resistance in Yeasts

(2008) M. Cuenca-Estrella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

(2008) J. L. Rodriguez-Tudela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro susceptibility of Cryptococcus gattii clinical isolates

(2008) A. Gomez-Lopez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Semi-national surveillance of fungaemia in Denmark 2004–2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

(2008) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole

(2008) A. Espinel-Ingroff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study

(2008) G. M. Gonzalez et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and outcome ofScedosporium prolificansinfection, a review of 162 cases

(2008) Juan Luis Rodriguez-Tudela et al.   MEDICAL MYCOLOGY

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE